Epidemiology and prevention of hepatitis B virus infection in China

被引:77
作者
Lu, F. M. [1 ]
Li, T. [1 ]
Liu, S. [2 ]
Zhuang, H. [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100191, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China
关键词
epidemiology; hepatitis B virus; prevention; transmission; vaccine; HEPATOCELLULAR-CARCINOMA; VACCINATION; RISK; CHILDREN; DISEASE; TAIWAN;
D O I
10.1111/j.1365-2893.2010.01266.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The concept of a hepatitis B vaccine was first introduced into China in 1978. China has been one of the first two developing countries to enact the universal hepatitis B vaccination programme for newborn babies in 1992, and has made tremendous achievements in the control of hepatitis B virus (HBV) infection since then. China now has both low and high endemic regions regarding HBV prevalence co-existing. Although China's drive to stop HBV spread has resulted in changes in HBV epidemic patterns, for the eventual elimination HBV infection in China, it is important to understand the current status of its epidemiology and the aspects of HBV transmission in different regions. More efforts are needed to improve and develop strategies for the control of HBV infection in China, particularly after implementing the policy of universal HBV immunization for all newborns.
引用
收藏
页码:4 / 9
页数:6
相关论文
共 40 条
[1]   THE EMERGENCE OF HEPATITIS-B AS A SEXUALLY-TRANSMITTED DISEASE [J].
ALTER, MJ ;
MARGOLIS, HS .
MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (06) :1529-1541
[2]   VACCINE AGAINST HUMAN HEPATITIS-B [J].
BUYNAK, EB ;
ROEHM, RR ;
TYTELL, AA ;
BERTLAND, AU ;
LAMPSON, GP ;
HILLEMAN, MR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (26) :2832-2834
[3]   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].
Chang, MH ;
Chen, CJ ;
Lai, MS ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Shau, WY ;
Chen, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859
[4]  
Cui FQ, 2006, CHIN J VACCINES IMMU, V12, P206
[5]  
DAI ZC, 1997, SEROEPIDEMIOLOGICA 1, P59
[6]  
Gong Jian, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P203
[7]  
Gong Xiao-hong, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P201
[8]  
HANG J K, 2009, S CHINA J PREV MED, V35, P38
[9]  
Hou Jinlin, 2005, Int J Med Sci, V2, P50
[10]   Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B [J].
Hsu, YS ;
Chien, RN ;
Yeh, CT ;
Sheen, IS ;
Chiou, HY ;
Chu, CM ;
Liaw, YF .
HEPATOLOGY, 2002, 35 (06) :1522-1527